PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 4, 20260 citations

Overview of systematic reviews and meta-analysis of risperidone on cardiovascular risk: analysis of Cochrane and non-Cochrane systematic reviews including 11,949 patients.

View Full Paper
SGSilvia Helena Soares GianiniIGIgor Soares GianiniAPAndrey Alves [UNIFESP] Porto

Key Points

  • To assess the cardiovascular effects of risperidone based on available systematic reviews and meta-analyses.
  • Reviewed Cochrane and non-Cochrane systematic reviews
  • Analyzed data from 11,949 patients
  • Evaluated quality and certainty of evidence
  • Evidence indicates low to very low certainty regarding cardiovascular effects of risperidone
  • Substantial uncertainty exists about the risks associated with risperidone
  • Calls for higher-quality systematic reviews with better reporting and methodology

Abstract

The available evidence from systematic reviews is of low to very low certainty and indicates substantial uncertainty regarding the cardiovascular effects of risperidone. Higher-quality systematic reviews with improved reporting and methodology are required.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Gianini et al. (2026) studied this question.

synapsesocial.com/papers/69a7cd3dd48f933b5eed967ahttps://doi.org/10.1080/13651501.2026.2637451
Ask AI
Helpful
Bookmark
Share
View Full Paper